By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Transition Therapeutics Inc. 

415 Yonge Street
Suite 1103
Toronto  Ontario  M5B2E7  Canada
Phone: 416-260-7770 Fax: 416-260-2886


Company News
Transition Therapeutics (TTH.TO) Announces Top Line Phase 2 Clinical Study Results Of Diabetes Drug Candidate TT401 2/1/2016 6:19:57 AM
Transition Therapeutics (TTH.TO) Announces Annual General Meeting Voting Results 1/6/2016 10:42:16 AM
Transition Therapeutics (TTH.TO) To Host Investor Day November 23 In New York 11/19/2015 11:07:17 AM
Transition Therapeutics (TTH.TO) Announces First Quarter Fiscal 2016 Financial Results 11/11/2015 8:43:19 AM
Transition Therapeutics (TTH.TO) To Hold Conference Call On First Quarter Fiscal 2016 Financial Results On Tuesday, November 10th, At 4:30 P.M. EST 11/2/2015 7:22:18 AM
Transition Therapeutics (TTH.TO) Announces Agreement For Phase 2 Study Of TT701 Drug Candidate 10/30/2015 6:13:40 AM
Transition Therapeutics (TTH.TO) Announces Presentation Of ELND005 Phase 2/3 Clinical Study Results At Clinical Trials In Alzheimer's Disease (CTAD) Conference 10/28/2015 10:41:18 AM
Transition Therapeutics (TTH.TO)'s Alzheimer's Drug Effective in ELND005 Phase II/III Study 10/15/2015 6:32:15 AM
Transition Therapeutics Inc. (TTH.TO) Announces Fiscal 2015 Financial Results 9/16/2015 11:32:08 AM
Transition Therapeutics Inc. (TTH.TO) To Hold Conference Call On Fiscal 2015 Financial Results On Tuesday, September 15th, At 4:30 P.M. EST 9/14/2015 11:12:27 AM